About
Huidagene is a biotechnology company developing gene therapies for ophthalmology, neurology, and neuromuscular diseases using CRISPR-Cas12/Cas13 and proprietary AAV platforms.
Explore Huidagene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.